Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice

Mutagenesis

Volumn 17, Issue 5, 2002, Pages 383-389

  Adler, I D ^a   Kliesch, U ^a   Jentsch, I ^a,b   Speicher, M R ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; DACARBAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; GENETIC RISK; GERM CELL; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; SOMATIC CELL; SPERMATID; SPERMATOGENESIS; SPERMATOZOON;

ANIMALIA;

EID: 0036733537     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/17.5.383     Document Type: Article

References (40)

1. New approaches to mutagenicity studies in animal carcinogenesis and mutagenic agents. I. Modification of the heritable translocation test
2. Cytogenetic tests in mammals
3. Comparison of the duration of spermatogenesis between male rodents and humans
4. Dose-response for heritable translocations induced by acrylamide in spermatids of mice
5. Cytogenetic effects of dacarbazine on mouse bone marrow cells in vivo
6. Dominant lethal mutations in mammals
7. Map of reciprocal translocations and insertions and cytogenetically visible deletions
8. Statistical methods for the dominant lethal assay
9. Phase II multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma
10. Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)
11. Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience
12. Phase III clinical trial of the combination of cisplatin, dacarbazine and carmustine with or without tamoxifen in patients with advanced malignant melanoma
13. Dominant mutations in mice
14. Procarbazine-induced specific locus mutations in male mice
15. Induction of specific-locus and dominant lethal mutations in male mice by chlormethine
16. Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide
17. Standard protocol for the dominant lethal test on male mice
18. Mutagenicity testing of vincristine sulfate in germ cells of male mice
19. Induction of specific locus and dominant lethal mutations in male mice by ifosfamide (Haloxa®)
20. An optimized, fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (M-FISH)
21. Treatment of advanced Hodgkin's lymphoma: Standard and experimental approaches
22. Standard normal chromosomes
23. An air-drying method for meiotic preparation from mammalian testis
24. An improved banding technique exemplified in the karyotype analysis of two strains of rats
25. Karyotyping mouse chromosomes by multiplex-FISH (M-FISH)
26. Treatment results of advanced neublastoma with the first Japanese study group protocol
27. Outpatient combination chemoimmunotherapy for patients with metastatic melanoma: Results of a phase I/II trial
28. Mutations induced by dacarbazine activated with cytochrome P450
29. Genetic effects of 1,3-butadiene and associated risk for heritable damage
30. 6-methylguanine-DNA methyltransferase
31. Chromosome specific paints from a high resolution flow karyotype of the mouse
32. Metabolic activation of dacarbazine by human cytochromes P450: The role of YCYP1A1, CYP1A2 and CYP2E1
33. Genetic Effects of Ionizing Radiation in Multicellular Eukaryotes and the Assessment of Genetic Radiation Hazard to Man
34. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes
35. 6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine
36. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma